MW: 149,035.80 Da
No. of AA: 1297
Abs 0.1% (g/L): 1.275
pI: 5.17
NCBI ID: CAA52275.1
UniprotKB: Q60393
Strains: 113/30, NCFB 3012
Associated Proteins:
Notes:
Nucleotide sequence of the gene coding for Clostridium botulinum (Clostridium argentinense) type G neurotoxin: genealogical comparison with other clostridial neurotoxins.
Campbell K, Collins MD, East AK. (1993). Biochim Biophys Acta.
DOI: 10.1016/0167-4781(93)90020-E PMID: 8268233
Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
Arndt JW, Yu W, Bi F, Stevens RC. (2005). Biochemistry.
DOI: 10.1021/bi0505924 PMID: 16008342
Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
Stenmark P, Dong M, Dupuy J, Chapman ER, Stevens RC. (2010). J Mol Biol.
DOI: 10.1016/j.jmb.2010.02.041 PMID: 20219474
Structural analysis of botulinum neurotoxin type G receptor binding.
Schmitt J1, Karalewitz A, Benefield DA, Mushrush DJ, Pruitt RN, Spiller BW, Barbieri JT, Lacy DB. (2010). Biochemistry.
DOI: 10.1021/bi100412v PMID: 20507178
Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity.
Strotmeier J, Willjes G, Binz T, Rummel A. (2012). FEBS Lett.
DOI: 10.1016/j.febslet.2011.12.037 PMID: 22265973
A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency.
Stern D, Weisemann J, Le Blanc A, von Berg L, Mahrhold S, Piesker J, Laue M, Luppa PB, Dorner MB, Dorner BG, Rummel A. (2018). PLoS Pathog.
DOI: 10.1371/journal.ppat.1007048 PMID: 29718991